相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
99
- 英文名:
Recombinant Mouse CD112R-Fc Chimera (carrier-free)
- 供应商:
北京云肽生物科技有限公司
美国 BioLegend 公司位于美国加州,致力于为生物医药研究的各个前沿领域提供高质量的抗体及其它相关试剂。BioLegend 虽然成立的时间不长,但它聚集了一批来自 PharMingen 公司的专业人士,建立了一支具有雄厚技术背景的专业队伍。通过其自身的先天优势,以及与世界知名实验室和研究所的良好合作关系,以合理的价格为广大客户提供高质量的免疫学和细胞生物学产品。
BioLegend 公司以其专业技术力量为保证,提供各种质量卓越的产品,并不断地开发新产品,以满足飞速发展的生命科学研究的需要。
BioLegend 776606 Recombinant Mouse CD112R-Fc Chimera (carrier-free)
产品简介:
产品品牌:BioLegend
产品货号:776606
产品名称:BioLegend 776606 Recombinant Mouse CD112R-Fc Chimera (carrier-free)
产品规格:100 µg
产品说明:
Regulatory Status RUO
Other Names
Poliovirus receptor-related immunoglobulin domain containing protein, PVRIG, C7orf15, CD112 receptor
描述
CD112R基因编码单个跨膜蛋白,该蛋白由单个细胞外IgV结构域、一个跨膜结构域和一个包含两个酪氨酸残基的长细胞内结构域组成,其中一个位于ITIM样基序内。CD112R最初被命名为PVRIG,因为在其第二外显子与脊髓hui质炎病毒受体(PVR/CD155)和脊髓hui质炎病毒受体样(PVRL)基因的可变免疫球蛋白结构域之间观察到同源性。CD112R是CD112/Nectin-2的细胞表面受体,并且可以作为抑制T细胞受体介导的信号的共抑制受体。在与CD112相互作用后,CD112R抑制T细胞增殖,而CD112R和CD112之间相互作用的破坏增强了T细胞反应,这表明CD112R是人类T细胞的新检查点。CD112R与CD226竞争CD112结合。已经表明,CD112R的阻断增强了曲妥珠单抗(治疗具有高Her2表达的癌症的一线药物)触发的人类NK细胞的抗肿瘤反应。
CD112R gene encodes a single transmembrane protein consisting of a single extracellular IgV domain, one transmembrane domain, and a long intracellular domain which contains two tyrosine residues, one within an ITIM-like motif. CD112R was initially named PVRIG for the homology observed between its second exon and the variable immunoglobulin domain of the 脊髓hui质炎病毒 receptor (PVR/CD155) and 脊髓hui质炎病毒 receptor-like (PVRL) genes. CD112R is a cell surface receptor for CD112/Nectin-2 and may act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals. Following interaction with CD112, CD112R inhibits T-cell proliferation and the disruption of interaction between CD112R and CD112 enhances T cell response, suggesting CD112R is a novel checkpoint for human T cells. CD112R competes with CD226 for CD112 binding. It has been shown the blockade of CD112R enhances Trastuzumab (first-line drug to treat breast cancer with high Her2 expression) triggered antitumor response by human NK cells.
Product Details
Source
Mouse CD112R, amino acids Ser35-Asp165 (Accession # A0A1B0GS01) with a C-terminal mouse IgG2a-Fc and 8-His tag was expressed in CHO cells.
Molecular Mass
The 384 amino acid recombinant protein has a predicted molecular mass of approximately 42.7 kD. The DTT-reduced protein migrates at approximately 50 kDa and non-reduced protein migrates at approximately 90 kD by SDS-PAGE. The predicted N-terminal amino acid is Ser.
Purity
> 95%, as determined by Coomassie stained SDS-PAGE.
Formulation
0.22 µm filtered protein solution is in PBS, pH 7.2
Endotoxin Level
Less than 0.1 EU per µg protein as determined by the LAL method.
Concentration
10-25 µg sizes are bottled at 200 µg/mL. 100 µg size is bottled at the concentration indicated on the vial.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
When mouse CD112R is immobilized at 1.0 µg/mL, biotinylated mouse CD112 binds with EC50 of 15 - 60 ng/mL.
Application Bioassay
Antigen Details
Structure Homodimer
Distribution
Preferentially expressed in lymphocytes, such as T cells and NK cells, but not in monocyte derived dendritic cells.
Function
Cell surface receptor for CD112 that may act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals.
Interaction T cell, NK cells
Ligand/Receptor CD112/Nectin-2
Bioactivity Measured by its ability to bind mouse CD112
Cell Type NK cells, T cells
Biology Area
Angiogenesis, Cancer Biomarkers, Cell Biology, Cell Motility/Cytoskeleton/Structure, Immunology
Molecular Family
Adhesion Molecules, Immune Checkpoint Receptors, Soluble Receptors, TCRs
以下是 BioLegend 品牌部分产品,如需其他产品请联系本公司销售。
BioLegend 100102 Purified anti-mouse CD2 RM2-5 500 ug
BioLegend 100104 Biotin anti-mouse CD2 RM2-5 500 ug
BioLegend 100107 PE anti-mouse CD2 RM2-5 50 ug
BioLegend 100108 PE anti-mouse CD2 RM2-5 200 ug
BioLegend 100111 APC anti-mouse CD2 RM2-5 25 ug
BioLegend 100112 APC anti-mouse CD2 RM2-5 100 ug
BioLegend 100203 FITC anti-mouse CD3 17A2 50 ug
BioLegend 100205 PE anti-mouse CD3 17A2 50 ug
BioLegend 100209 Alexa Fluor® 647 anti-mouse CD3 17A2 100 ug
BioLegend 100210 Alexa Fluor® 488 anti-mouse CD3 17A2 100 ug
BioLegend 100212 Alexa Fluor® 488 anti-mouse CD3 17A2 25 ug
BioLegend 100213 Pacific Blue™ anti-mouse CD3 17A2 25 ug
BioLegend 100214 Pacific Blue™ anti-mouse CD3 17A2 100 ug
BioLegend 100215 Alexa Fluor® 700 anti-mouse CD3 17A2 25 ug
BioLegend 100217 PerCP/Cyanine5.5 anti-mouse CD3 17A2 25 ug
BioLegend 100218 PerCP/Cyanine5.5 anti-mouse CD3 17A2 100 ug
BioLegend 100220 PE/Cyanine7 anti-mouse CD3 17A2 100 ug
BioLegend 100221 APC/Cyanine7 anti-mouse CD3 17A2 25 ug
BioLegend 100222 APC/Cyanine7 anti-mouse CD3 17A2 100 ug
BioLegend 100227 Brilliant Violet 421™ anti-mouse CD3 17A2 125 uL
BioLegend 100228 Brilliant Violet 421™ anti-mouse CD3 17A2 50 ug
BioLegend 100229 Brilliant Violet 650™ anti-mouse CD3 17A2 125 uL 
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Mouse as Model System to Study Host‐Pathogen Interactions in Influenza A Infections
and treated mice. Curr. Protoc. Mouse Biol. 1:17‐53. Angus, D.W., Baker, J.A., Mason, R., and Martin, I.J. 2008. The potential influence of CO2, as an agent for euthanasia
The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
, A., Gertsenstein, M., Vintersten, K., and Behringer, R. 2006a. Preparing mouse embryo fibroblasts. Cold Spring Harb. Protoc. doi: 10.1101/pdb.prot4398.[Free Full Text] Nagy, A., Gertsenstein, M., Vintersten, K., and Behringer, R. 2006b. De novo isolation
The OP9-DL1 System: Generation of T-Lymphocytes from Embryonic or Hematopoietic Stem Cells In Vitro
Full Text] Nagy, A., Gertsenstein, M., Vintersten, K., and Behringer, R. 2006a. Preparing mouse embryo fibroblasts. Cold Spring Harb. Protoc. doi: 10.1101/pdb.prot4398.[Free Full Text] Nagy, A., Gertsenstein, M., Vintersten, K
技术资料暂无技术资料 索取技术资料









